|
Status |
Public on Jan 12, 2013 |
Title |
Gene profile of glioblastoma cells treated with y15 and temozolomide |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
The gene expression profiles were identified in glioblastoma cells treated with FAK inhibitor Y15, temozolomide alone or with combination of Y15 and Temozolomide
|
|
|
Overall design |
DBTRG and U87 were treated with FAK inhibitor Y15 at 10 microM for 24 h; U87 cells were treated with Temozolomide 100 microM for 24 h and Y15+temozolomide at the same dose as each agent alone
|
|
|
Contributor(s) |
Golubovskaya V, Cance W, Liu S, Hu Q, Conroy J, Huang G, Ho B |
Citation(s) |
23387973 |
|
Submission date |
Jan 11, 2013 |
Last update date |
Aug 13, 2018 |
Contact name |
Qiang Hu |
E-mail(s) |
Qiang.Hu@RoswellPark.org
|
Organization name |
Roswell Park Cancer Institute
|
Street address |
Elm & Carlton Streets
|
City |
Buffalo |
State/province |
NY |
ZIP/Postal code |
14263 |
Country |
USA |
|
|
Platforms (1) |
GPL10558 |
Illumina HumanHT-12 V4.0 expression beadchip |
|
Samples (12)
|
|
Relations |
BioProject |
PRJNA186439 |